|
1
|
Broniarczyk J, Olejnik-Schmidt AK, Luczak
MW, Schmidt MT, Dabrowski M, Józefiak A, Kedzia W, Kwaśniewska A
and Goździcka-Józefiak A: Analysis of expression and structure of
the TSG101 gene in cervical cancer cells. Int J Mol Med.
25:777–783. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li L, Li X, Francke U and Cohen SN: The
TSG101 tumor susceptibility gene is located in chromosome 11 band
p15 and is mutated in human breast cancer. Cell. 88:143–154. 1997.
View Article : Google Scholar
|
|
3
|
Singh RK, Dasgupta S, Bhattacharya N,
Chunder N, Mondal R, Roy A, Mandal S, Roychowdhury S and Panda CK:
Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are
independently associated with the development of uterine cervical
carcinoma. J Cancer Res Clin Oncol. 131:395–406. 2005. View Article : Google Scholar
|
|
4
|
Carstens MJ, Krempler A, Triplett AA, Van
Lohuizen M and Wagner KU: Cell cycle arrest and cell death are
controlled by p53-dependent and p53-independent mechanisms in
Tsg101-deficient cells. J Biol Chem. 279:35984–35994. 2004.
View Article : Google Scholar
|
|
5
|
Koonin EV and Abagyan RA: TSG101 may be
the prototype of a class of dominant negative ubiquitin regulators.
Nat Genet. 16:330–331. 1997. View Article : Google Scholar
|
|
6
|
Ponting CP, Cai YD and Bork P: The breast
cancer gene product TSG101: a regulator of ubiquitination? J Mol
Med. 75:467–469. 1997.PubMed/NCBI
|
|
7
|
Watanabe M, Yanagi Y, Masuhiro Y, Yano T,
Yoshikawa H, Yanagisawa J and Kato S: A putative tumor suppressor,
TSG101, acts as a transcriptional suppressor through its
coiled-coil domain. Biochem Biophys Res Commun. 245:900–905. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hittelman AB, Burakov D, Iñiguez-Lluhí JA,
Freedman LP and Garabedian MJ: Differential regulation of
glucocorticoid receptor transcriptional activation via
AF-1-associated proteins. EMBO J. 18:5380–5388. 1999. View Article : Google Scholar
|
|
9
|
Babst M, Odorizzi G, Estepa EJ and Emr SD:
Mammalian tumor susceptibility gene 101 (TSG101) and the yeast
homologue, Vps23p, both function in late endosomal trafficking.
Traffic. 1:248–258. 2000. View Article : Google Scholar
|
|
10
|
Garrus JE, von Schwedler UK, Pornillos OW,
et al: Tsg101 and the vacuolar protein sorting pathway are
essential for HIV-1 budding. Cell. 107:55–65. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu Q, Hope LW, Brasch M, Reinhard C and
Cohen SN: TSG101 interaction with HRS mediates endosomal
trafficking and receptor down-regulation. Proc Natl Acad Sci USA.
100:7626–7631. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bache KG, Brech A, Mehlum A and Stenmark
H: Hrs regulates multivesicular body formation via ESCRT
recruitment to endosomes. J Cell Biol. 162:435–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhong Q, Chen Y, Jones D and Lee WH:
Perturbation of TSG101 protein affects cell cycle progression.
Cancer Res. 58:2699–2702. 1998.PubMed/NCBI
|
|
14
|
Xie W, Li L and Cohen SN: Cell
cycle-dependent subcellular localization of the TSG101 protein and
mitotic and nuclear abnormalities associated with TSG101
deficiency. Proc Natl Acad Sci USA. 95:1595–1600. 1998. View Article : Google Scholar
|
|
15
|
Ruland J, Sirard C, Elia A, MacPherson D,
Wakeham A, Li L, de la Pompa JL, Cohen SN and Mak TW: p53
accumulation, defective cell proliferation, and early embryonic
lethality in mice lacking tsg101. Proc Natl Acad Sci USA.
98:1859–1864. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krempler A, Henry MD, Triplett AA and
Wagner KU: Targeted deletion of the Tsg101 gene results in cell
cycle arrest at G1/S and p53-independent cell death. J Biol Chem.
277:43216–43223. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wagner KU, Krempler A, Qi Y, Park K, Henry
MD, Triplett AA, Riedlinger G, Rucker EB and Hennighausen L: Tsg101
is essential for cell growth, proliferation, and cell survival of
embryonic and adult tissues. Mol Cell Biol. 23:150–162. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim CH, Heath C, Bertuch A and Hansen U:
Specific stimulation of simian virus 40 late transcription in vitro
by a cellular factor binding the simian virus 40 21-base-pair
repeat promoter element. Proc Natl Acad Sci USA. 84:6025–6029.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swendeman SL, Spielholz C, Jenkins NA,
Gilbert DJ, Copeland NG and Sheffery M: Characterization of the
genomic structure, chromosomal location, promoter, and development
expression of the alpha-globin transcription factor CP2. J Biol
Chem. 269:11663–11671. 1994.
|
|
20
|
Cunningham JM, Vanin EF, Tran N, Valentine
M and Jane SM: The human transcription factor CP2 (TFCP2), a
component of the human gamma-globin stage selector protein, maps to
chromosome region 12q13 and is within 250kb of the NF-E2 gene.
Genomics. 30:398–399. 1995.
|
|
21
|
Venkatesan K, McManus HR, Mello CC, Smith
TF and Hansen U: Functional conservation between members of an
ancient duplicated transcription factor family, LSF/Grainyhead.
Nucleic Acids Res. 31:4304–4316. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wilanowski T, Tuckfield A, Cerruti L,
O’Connell S, Saint R, Parekh V, Tao J, Cunningham JM and Jane SM: A
highly conserved novel family of mammalian developmental
transcription factors related to Drosophila grainyhead. Mech Dev.
114:37–50. 2002. View Article : Google Scholar
|
|
23
|
Traylor-Knowles N, Hansen U, Dubuc TQ,
Martindale MQ, Kaufman L and Finnerty JR: The evolutionary
diversification of LSF and Grainyhead transcription factors
preceded the radiation of basal animal lineages. BMC Evol Biol.
10:102010. View Article : Google Scholar
|
|
24
|
Santhekadur PK, Rajasekaran D, Siddiq A,
Gredler R, Chen D, Schaus SE, Hansen U, Fisher PB and Sarkar D: The
transcription factor LSF: a novel oncogene for hepatocellular
carcinoma. Am J Cancer Res. 2:269–285. 2012.PubMed/NCBI
|
|
25
|
Shirra MK and Hansen U: LSF and NTF-1
share a conserved DNA recognition motif yet require different
oligomerization states to form a stable protein-DNA complex. J Biol
Chem. 273:19260–19268. 1998. View Article : Google Scholar
|
|
26
|
Kokoszynska K, Ostrowski J, Rychlewski L
and Wyrwicz LS: The fold recognition of CP2 transcription factors
gives new insights into the function and evolution of tumor
suppressor protein p53. Cell Cycle. 7:2907–2915. 2008. View Article : Google Scholar
|
|
27
|
Drouin EE, Schrader CE, Stavnezer J and
Hansen U: The ubiquitously expressed DNA-binding protein late SV40
factor binds Ig switch regions and represses class switching to
IgA. J Immunol. 168:2847–2856. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zambrano N, Minopoli G, de Candia P and
Russo T: The Fe65 adaptor protein interacts through its PID1 domain
with the transcription factor CP2/LSF/LBP1. J Biol Chem.
273:20128–20133. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hansen U, Owens L and Saxena UH:
Transcription factors LSF and E2Fs: tandem cyclists driving G0 to
S? Cell Cycle. 8:2146–2151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Powell CM, Rudge TL, Zhu Q, Johnson LF and
Hansen U: Inhibition of the mammalian transcription factor LSF
induces S-phase-dependent apoptosis by downregulating thymidylate
synthase expression. EMBO J. 19:4665–4675. 2000. View Article : Google Scholar
|
|
31
|
Manos MM, Ting Y, Wright DK, et al: The
use of polymerase chain reaction amplification for the detection of
genital human papillomaviruses. Cancer Cells. 7:209–214. 1989.
|
|
32
|
Yoshikawa H, Kawana T, Kitagawa K, Mizuno
M, Yoshikura H and Iwamoto A: Detection and typing of multiple
genital human papillomaviruses by DNA amplification with consensus
primers. J Cancer Res. 82:524–531. 1991.PubMed/NCBI
|
|
33
|
Daud II and Scott ME: Validation of
reference genes in cervical cell samples from human
papillomavirus-infected and -uninfected women for quantitative
reverse transcription-PCR assays. Clin Vaccine Immunol.
15:1369–1373. 2008. View Article : Google Scholar
|
|
34
|
Wagner KU, Dierisseau P, Rucker EB,
Robinson GW and Hennighausen L: Genomic architecture and
transcriptional activation of the mouse and human tumor
susceptibility gene TSG101: common types of shorter transcripts are
true alternative splice variants. Oncogene. 17:2761–2770. 1998.
View Article : Google Scholar
|
|
35
|
Liu RT, Huang CC, You HL, Chou FF, Hu CC,
Chao FP, Chen CM and Cheng JT: Overexpression of tumor
susceptibility gene TSG101 in human papillary thyroid carcinomas.
Oncogene. 21:4830–4837. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Young TW, Mei FC, Rosen DG, Yang G, Li N,
Liu J and Cheng X: Up-regulation of tumor susceptibility gene 101
protein in ovarian carcinomas revealed by proteomics analyses. Mol
Cell Proteomics. 6:294–304. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kidd M, Nadler B, Mane S, Eick G,
Malfertheiner M, Champaneria M, et al: GeneChip, geNorm and
gastrointestinal tumors: novel reference genes for real-time PCR.
Physiol Genomics. 30:363–370. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Swendeman SL, Spielholz C, Jenkins NA,
Gilbert DJ, Copeland NG and Sheffery M: Characterization of the
genomic structure, chromosomal location, promoter, and
developmental expression of the B-globin transcription factor CP2.
J Biol Chem. 269:11663–11671. 1994.PubMed/NCBI
|
|
39
|
Ramamurthy L, Barbour V, Tuckfield A,
Clouston DR, Topham D, Cunningham JM, et al: Targeted disruption of
the CP2 gene, a member of the NTF family of transcription factors.
J Biol Chem. 276:7836–7842. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saxena UH, Powell CMH, Fecko JK, Cacioppo
R, Chou HS, Cooper GM and Hansen U: Phosphorylation by cyclin
C/cyclin-dependent kinase 2 following mitogenic stimulation of
murine fibroblasts inhibits transcriptional activity of LSF during
G1 progression. Mol Cell Biol. 29:2335–2345. 2009. View Article : Google Scholar
|
|
41
|
Coull JJ, Romerio F, Sun JM, Volker JL,
Galvin KM, Davie JR, Shi Y, Hansen U and Margolis DM: The human
factors YY1 and LSF repress the human immunodeficiency virus type 1
long terminal repeat via recruitment of histone deacetylase 1. J
Virol. 74:6790–6799. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lace MJ, Yamakawa Y, Ushikai M, Anson JR,
Hangen TH and Turek LP: Cellular factor YY1 downregulates the human
papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a
negative element overlapping the transcrition-initiation site. J
Gen Virol. 90:2402–2412. 2009. View Article : Google Scholar
|
|
43
|
Fan R, Chen P, Zhao D, Tonq JL, Li J and
Liu F: Cooperation of deregulated Notch signaling and Ras pathway
in human hepatocarcinogenesis. J Mol Histol. 42:473–481. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zagouras P, Stifani S, Blaumeller CM,
Carcangiu ML and Artavanis-Tsakonas S: Alterations in Notch
signaling in neoplastic lesions of human cervix. Proc Natl Acad Sci
USA. 92:6414–6418. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Leethanakul C, Patel V, Gillespie J,
Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M and
Gutkind JS: Distinct pattern of expression of differentiation and
growth-related genes in squamous cell carcinomas of the head and
neck revealed by use of laser capture microdissection and cDNA
arrays. Oncogene. 19:3220–3224. 2000. View Article : Google Scholar
|
|
46
|
Westhoff B: Colaluca IN, D’Ario G,
Donzelli M, Tosoni D, Volorio S, Pelosi G, Spaggiari L, Mazzarol G,
Viale G, Pece S and Di Fiore PP, Alterations of the Notch pathway
in lung cancer. Proc Natl Acad Sci USA. 106:22293–22298.
2009.PubMed/NCBI
|
|
47
|
Zhang Y, Li B, Ji ZZ and Zheng PS: Notch 1
regulates the growth of human colon cancer. Cancer. 116:5207–5218.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Okuhashi Y, Nara N and Tohoda S: Effects
of gamma-secretase inhibitors on the growth of leukemia cells.
Anticancer Res. 30:495–498. 2010.PubMed/NCBI
|
|
49
|
Shlomai A: Targeting late SV40 factor: is
the achilles heel of hepatocarcinogenesis revealed? World J
Gastroenterol. 18:6709–6711. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Veljkovic J and Hansen U: Lineage-specific
and ubiquitous biological roles of the mammalian transcription
factor LSF. Gene. 343:23–40. 2004. View Article : Google Scholar : PubMed/NCBI
|
